This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1973 Mar;47(3):680P-681P.

The buccal absorption of some -adrenoceptor blocking drugs

PMID: 4147199
PMCID: PMC1776362

The buccal absorption of some -adrenoceptor blocking drugs

D C Hicks. Br J Pharmacol. 1973 Mar.

. 1973 Mar;47(3):680P-681P.

Author

PMID: 4147199
PMCID: PMC1776362

No abstract available

PubMed Disclaimer

Similar articles

Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.
Bodem G, Chidsey CA. Bodem G, et al. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):26-9. doi: 10.1002/cpt197314126. Clin Pharmacol Ther. 1973. PMID: 4405104 No abstract available.
The buccal absorption of vitamin C.
Odumosu A, Wilson CW. Odumosu A, et al. Proc Nutr Soc. 1971 Dec;30(3):81A-82A. Proc Nutr Soc. 1971. PMID: 5154131 No abstract available.
Influence of pH on absorption of thymoxamine through buccal mucosa in man.
Arbab AG, Turner P. Arbab AG, et al. Br J Pharmacol. 1971 Oct;43(2):479P-480P. Br J Pharmacol. 1971. PMID: 5158249 Free PMC article. No abstract available.
[Biotransformation and pharmacokinetics of beta-receptor blockaders].
Pfeifer S, Zimmer C. Pfeifer S, et al. Pharmazie. 1975 Oct;30(10):625-33. Pharmazie. 1975. PMID: 685 Review. German. No abstract available.
Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
Shand DG. Shand DG. Drugs. 1974;7(1):39-47. doi: 10.2165/00003495-197407010-00003. Drugs. 1974. PMID: 4151694 Review. No abstract available.

See all similar articles

Cited by

Transbuccal delivery of acyclovir: I. In vitro determination of routes of buccal transport.
Shojaei AH, Berner B, Xiaoling L. Shojaei AH, et al. Pharm Res. 1998 Aug;15(8):1182-8. doi: 10.1023/a:1011927521627. Pharm Res. 1998. PMID: 9706047
Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G, Regàrdh CG. Johnsson G, et al. Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001. Clin Pharmacokinet. 1976. PMID: 13958 Review.
A study of the influence of pH on the buccal absorption and renal excretion of procainamide.
Meyer W, Kaye CM, Turner P. Meyer W, et al. Eur J Clin Pharmacol. 1974 Jul 26;7(4):287-9. doi: 10.1007/BF00560346. Eur J Clin Pharmacol. 1974. PMID: 4850327 No abstract available.
Bioavailability of propranolol after oral, sublingual, and intranasal administration.
Duchateau GS, Zuidema J, Merkus FW. Duchateau GS, et al. Pharm Res. 1986 Apr;3(2):108-11. doi: 10.1023/A:1016345504153. Pharm Res. 1986. PMID: 24271469
Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.
Hinderling PH, Schmidlin O, Seydel JK. Hinderling PH, et al. J Pharmacokinet Biopharm. 1984 Jun;12(3):263-87. doi: 10.1007/BF01061721. J Pharmacokinet Biopharm. 1984. PMID: 6150103

See all "Cited by" articles

References

1. J Pharm Pharmacol. 1967 Dec;19:Suppl:31S-41S - PubMed
1. Int Z Klin Pharmakol Ther Toxikol. 1968;1(6):467-74 - PubMed
1. J Pharm Pharmacol. 1971 Dec;23:68S-72S - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources